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Regulation of the Differentiation of PC12
Pheochromocytoma Cells
by Ko Fujita,* Philip Lazarovici,* and Gordon Guroff*
The PC12 clone, developed from apheochromocytoma tumor ofthe rat adrenal medulla, has become apre-
miere model for the study ofneuronal differentiation. When treated in culture with nanomolar concentra-
tions ofnerve growth factor, PC12 cells stop dividing, elaborate processes, become electrically excitable, and
will make synapses with appropriate muscle cells in culture. The changes induced by nerve growth factorlead
to cells that, by any numberofcriteria, resemble mature sympathetic neurons. These changes are accompa-
nied by a series ofbiochemical alterations occurring in the membrane, the cytoplasm, andthe nucleus ofthe
cell. Some ofthese events are independent ofchanges in transcription, while others clearly involve changes
in gene expression. A numberofthe alterations seen in the cells involve increases or decreases in the phos-
phorylation ofkeycellularproteins. The information available thus farallowstheconstruction ofahypothesis
regarding the biochemical basis ofPC12 differentiation.
Introduction
Between 1948, when the first definable experiment on
nerve growth factor (NGF) was published, and 1976,
when the first report on PC12 cells appeared, there was
relatively little progress toward anunderstanding ofthe
mechanisms by which nerve growth factor acts on its tar-
get cells. The reason for this difficulty is that the classi-
cal targets of nerve growth factor, sympathetic and sen-
sory neurons, are difficult to harvest, difficult to culture,
and, above all, absolutely dependent on nervegrowthfac-
tor for survival. Thus, any experiments directed toward
the biochemical or molecular consequences of nerve
growthfactor action onthese cells suffered fromthe criti-
cism that the controls, those notgiven nerve growth fac-
tor, were dying. In short, it was difficult if not impossi-
ble to say whether a given biochemical response was a
specific action of nerve growth factor or simply a result
ofthe factthatthe cells were not dying. Clearly, atool was
neededwithwhich to study the actions ofthe factorinthe
absence of the confounding consideration of frank sur-
vival. Such a tool was provided by the development of
PC12 cells. These cells are currently thepremiere tool for
the study of nerve growth factor, but, more than that,
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they have become a very important model for the study
of neuronal differentiation. Indeed, the findings with
PC12 cells, in some cases, have implications for differen-
tiation of cells in general.
Properties of PC12 Cells
PC12 cells were clonedfrom a solidpheochromocytoma
tumorpassaged subcutaneously in New England Deacon-
ess Hospital strainwhite rats (1). The original report in-
dicated that the cells had a chromosome numberof40 and
exhibited no discernable changes in properties for the
first 70 passages in culture. The cells contained dense-
core, chromaffinlike vesicles and catecholamines were
foundbyhistofluorescense methodology. Upon treatment
with NGF the cells appeared to stop dividingand elabo-
rated branched, varicose processes. Removal ofNGF led
to adegenerationoftheprocesses and aresumptionofcell
division, indicating that the effects of NGF were rather
readily reversible. Subsequent studies showed that the
NGF-induced cessation ofcell division and elaboration of
processes was accompanied by the development ofelec-
trical excitability and an increased sensitivity toiontopho-
retically applied acetylcholine (2). The neuronlike charac-
ter ofthe NGF-differentiated cells was validated by the
demonstration that the cells would form functional
cholinergic synapses with myotubes from the clonal rat
skeletal muscle line L6 (3).
PC12 cells are small (6-14M.m in diameter), round, cat-
echolamine-containing cells thatgrow in standard, serum-FUJITA, LAZAROVICI, AND GUROFF
supplemented medium with a doubling time ofbetween
48 and 96 hr. They attach to plastic culture surfaces, but
relatively loosely, and so for normal maintenance, tryp-
sinization is not necessary. Forlong-term studies with the
cells, collagen orpolylysine substrates are advisable. The
cells are ratherplastic in that the cultures become some-
what heterogeneous in morphology after 25 to 35 pas-
sages. They can be grown in serum-free medium, or in
suspension cultures, although the characteristics ofcells
grown under such conditions have not been explored as
extensively as have those ofcells grown as monolayers in
serum-containing medium.
Unlike the adrenal medulla, inwhichnorepinephrine is
the major catecholamine, the PC12 cells contain primar-
ily dopamine (1,4), on the order of 15 nmole/mg cellular
protein. The norepinephrine content is about one-third to
one-tenth that ofdopamine, and little or no epinephrine
is found. The cells will take up catecholamines from the
mediumby a system similar to thatfound in sympathetic
neurons and store them in chromaffin-type granules (5).
The cells will release catecholamines in a Ca2 +-dependent
fashion in response to depolarization(6); stimulation ofthe
cells with nicotinic cholinergic agonists also causes
catecholamine release (7). The cells will synthesize, store,
and release acetylcholine (8). The storage granules that
contain acetylcholine appear to be ofthe dense-core va-
riety, similar to those that contain catecholamines, rather
than the translucent granules usually found in choliner-
gic nerve terminals (9).
The enzymes for the synthesis of catecholamines are
also present in PC12 cells (1). The tyrosine hydroxylase
has been inspected in detail, both for the short-term in-
fluences on its activity (10,11) and for regulation of its
transcription (12,13). The dopamine p-hydroxylase of
these cells has been found to be a glycoprotein contain-
ing two subunits ofmolecular weights 73,000 and 77,000
that occur in almost equal amounts in the molecule (14);
the biosynthesis ofthe soluble and the membrane-bound
forms ofthe enzyme has also been studied (15). There is
some suggestion in the early work that the preponder-
ance of dopamine over norepinephrine in these cells is
due, not to adeficiency ofdopamineP-hydroxylase, but to
a relative lack of ascorbic acid, a necessary cofactor for
this enzyme (16). Choline acetyltransferase is found in
PC12 cells (3,8) and its induction by NGF has been
studied (17). Acetylcholinesterase is also, of course, pres-
ent and appears to exist in three molecularforms, 4, 6.5,
and 10S, in dividing cells (18). Treatment with NGF
causes the appearance of a small amount of a 16S form.
The cells have receptors for a number of different
ligands. The receptors for NGF are found in two differ-
ent forms (19,20). These forms are distinguished on the
basis of their off-time, the rate with which the ligand,
NGF, is released from its binding site. About 95% ofthe
total receptors are so-called "fast" receptors, with an off-
time of some 30 sec; theremainder "slow" receptors, have
an off-time on the order of30 min. The fast receptor ap-
pears to have an affinity constant ofabout 1 nM, the slow
receptor binds NGF about 100 times more tightly. When
PC12 cells are treated withtrypsin orextractedwith Tri-
ton X-100, the number offast receptors is depleted; the
slow receptors are relativelyresistant to thesetreatments
(21). The molecular weight ofthe low-affinity receptor is
on the order of90,000, that ofthe high-affinity site some-
where between 160,000 and 200,000, although both are
reported to contain the same protein at the binding site
(22). The molecular relationship between these two forms
ofthe receptor is not known in detail, but it iswidely as-
sumed that the high-affinity receptor is responsible for
thephysiological actions that nervegrowthfactor exerts
on the cells. Indeed, there is good evidence to indicate
that only the high-affinity form is internalized (23), and
mutants that express onlythelow-affinity form do not re-
spond to NGF (24). The general properties of the NGF
receptors on PC12 cells are summarized in Table 1. The
cells displayreceptorsfor the mitogen epidermalgrowth
factor(25,26) andthese receptors are down-regulated by
NGF (25,27). It has also been reported that two classes
of epidermal growth factor receptors can be seen (28).
Receptors forfibroblastgrowth factor are alsopresent on
PC12 cells (29).
The acetylcholine sensitivity ofthe PC12 cells is due to
the presence of both nicotinic and muscarinic acetyl-
choline receptors. Stimulation ofthe nicotinic receptors
leads to the release ofcatecholamines (7). These receptors
appearto be similartothose seen on sympathetic neurons
(30,31), and cross-react with a monoclonal antibody pre-
pared against chicken brain nicotinic receptors (32). The
muscarinic receptors appear to be comparable to those
found on adrenal medullary cells (33). Stimulation ofthe
muscarinic receptors is reported to cause an influx of
Ca2 + and an increase in the hydrolysis ofphosphoinosi-
Table 1. Properties of the nerve growth factor receptors ofPC12 cells.
Property High affinity, slow receptors Low affinity, fast receptors References
Affinity 5-20 x 10- "M 0.2-3.2 x 10-9M (20,205-207)
Dissociation rate 4-5.8 x 10-4S- 1 2-2.3 x 10 -2 (19,20)
Receptor number/cell 2,500-15,000 45,000-180,000 (20,205-207)
Molecular weight
Core protein Unknown 42,478 (198,199,208)
Mature receptor after "'\90,000 "'70,000-83,000 (22,198,199,208)
glycosylation and sialylation
After cross-linking 135,000-225,000 87,000-107,000 (22,209-211)
Detergent extractability Resistant Susceptible (206)
Sensitivity to proteolysis No Yes (19,206)
Sequestration and internalization Yes No (23,197)
Transduction of NGF signal Yes No (212)
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tides (34,35). PC12 cells are rich in adenosine receptors
(36), and at least some ofthese receptors are coupled to
adenylate cyclase. The receptors appear to be ofthe A2
type (37,38). Enkephalin receptors have been reported
(39) and these receptors increase in number upon treat-
ment of the cells with NGF. There is also indirect evi-
dence thatthe cells display receptors forbradykinin (40).
The ability ofPC12 cells to conduct electrical signals is
determined bythepresence and characteristics ofspecific
ion-conducting components localized within the plasma
membrane. These ionic channels selectivelyregulate the
transmembrane fluxes ofNa , K , and Ca2+ and most
are sensitive to the transmembrane voltage. Besides be-
ing involved in the propagation ofelectrical activity, these
channels regulate neurotransmitter release, enzymatic
reactions, and receptorfunction. Avariety ofion channels
have been detected in PC12 cells (41,42). There are
voltage-dependent Na+ channels, voltage-dependent
Ca2 + channels, voltage-dependent K+ channels, and
Ca2+-dependent K+ channels. Ion channels are also seen
on the growth cones ofPC12 cells induced to form neu-
rites with NGF. Evidence hasbeenpresentedto indicate
that the growth cones display Na+ channels, two types
ofCa2+ channels, and more than one type ofK+ channel
(43).
Much ofthe present effort is directed toward an explo-
ration of the various calcium channels. It is clear that
more than one type of calcium channel can be found on
the membranes ofthese cells. There are studies indicat-
ingthat the uptake ofcalcium is altered by the presence
ofethanol(44-46). Anumberofexperiments suggestthat
at least one type ofcalcium channel is regulated byphos-
phorylation byprotein kinase C(47-50). Theuptake ofcal-
ciumby specific channels hasbeencorrelated with trans-
mitterrelease (51). Inthe absence ofnervegrowthfactor,
PC12 cells are electrically inexcitable (42)because ofthe
very low density of Na+ channels present, although a
sufficient number ofvoltage-dependent K+ channels are
found. Upon treatment with NGF there is agradual 10-
to 20-fold increase in the density of Na+ channels (52),
and the cells acquire neuronal excitability. Finally, the
PC12 cells appear to be one ofthe richest known sources
ofthe Ca2+-activated, apamin-sensitive K+ channel(53).
A number of PC12 cell mutants have been described.
Among the first was PC12h (54), a subelone that, unlike
the parent PC12, exhibits an induction oftyrosine hydrox-
ylase upon treatment with NGF. There are several vari-
antsthatlackthe NGFreceptors(55), althoughthese cells
are quite different thantheparent, anditisgenerallyfelt
thatthey are more than simple receptordeletions. Clones
that react slowly to NGF and those that respond faster
have been studied (56). Adenosine kinase-deficient cells
havebeenprepared(57), ashave cellswith analtered re-
sponse to dBcAMP (58). A PC12 mutant thatlacks a cell
surface heparan sulfate proteoglyean hasbeenreported,
and this mutant has an altered distribution ofone ofthe
forms of acetylcholinesterase (59). One of the most in-
teresting reports has been of the mutant, mentioned
above, that lacks high-affinity or slow receptors (24).
There are clones that are deficientincatecholaniine trans-
port (60), and clones that have a defect in one of the
cAMP-dependent proteinkinases(61). A subline hasbeen
reported in which cAMP mimics the actions of nerve
growth factor on neurite outgrowth (62). Finally, there is
a clone forwhich NGF, instead ofbeing a differentiating
agent andinhibitingproliferation as it does in the parent,
appears to be a mitogen (63). This increasing catalog of
subclones gives promise of allowing a dissection of the
various properties of the PC12 cells.
Properties of the Differentiating
Agent, Nerve Growth Factor
The first definable experiments on NGF showed that
fragments of tumor, implanted in chick embryos, elabo-
rated a substance that enhanced neurite outgrowth from
sensory and sympathetic neurons (64,65). The demonstra-
tionthatthisphenomenon couldbe duplicatedinvitro(66)
ledtotheisolation andpurification ofapeptide ofmolecu-
larweight 26,000 (67). The physiological relevance ofthis
factorwas demonstrated inexperimentsinwhichthepep-
tide was used as antigen. The antiserum elicited, when
injected into neonatal rodents, what is now called "im-
munosympathectomy," thepermanent andnear-total dis-
appearance ofthe sympathetic nervous system (68). The
interpretation ofthisexperiment isthat NGF isrequired,
virtually moment to moment, for the survival of sym-
pathetic neurons. Subsequent work has shown that this
is true for sensory neurons in prenatal rodents as well
(69).
The NGF canbe isolated intwo differentfonns. The 7S
fonncontains three differentkindsofsubunits, thealphas,
thebeta, andthegammas, andhas amolecularweight of
some 140,000(70,71). The exactfunctionsofthealphasand
the gammas are notknown. The gammamaybe involved
in the processing ofthe active beta subunit; the complex
itselfmaybeformedfortheprotection, the storage, orthe
transport ofthe beta. The beta is a noncovalently linked
dimer, ofmolecularweight 26,000, containing two atoms
ofzinc, andhasallthebiological activity. It canbeisolated
in aform, slightlymodifiedbyproteolysis, calledthe2.5S
(72). The monomerofthebetadimerhasbeensequenced.
The observation that NGF has some homology to insulin
(73) has placed it in the family ofinsulinlike growth fac-
tors.
The gene for NGF has been identified in both mouse
and human(74,75). These studies showthat there is 86%
homology between the two species. One copy ofthe gene
exists in each species andinhumans thegeneisfound on
chromosome 1 (76). The probes that have become avail-
able through this work have allowed a determination of
the levels ofNGF mRNA, andbyinference, the rates of
transcription, in various tissues. Through these studies
it has been shown that the synthesis of NGF occurs in
those tissues innervatedby sympathetic and sensory neu-
rons and that the levels ofsynthesis are proportional to
the amounts ofthat innervation(77,78). The original con-
clusion that innervation actually increased the level of
NGF synthesis has nowgivenwaytothe conceptthatthe
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synthesis is controlled by the intrinsic developmental pro-
gram of the cells that are targets for innervation.
NGF is found in remarkably large amounts in the sub-
maxillary gland ofthe mature male mouse. The biologi-
cal purpose ofthis richness is obscure, but these glands
have provided atractable source ofNGF, andthisunprec-
edented andready access to milligram quantities ofpure
material has been responsible for the large body ofbio-
logical information now available about this factor. NGF
also occurs in large quantities inguineapigprostate (79),
and in the seminal fluid of the bull (80). NGFs with
reasonable homology to the mouse material havebeeniso-
lated from snake venom(81), and NGF has been isolated
from conditioned mediafrom anynumber ofcultured cells
(82). A material having NGF activity has been found in
human placenta (83), but detailed characterization ofthis
material has not been presented.
It has been thought that, in general, the cells that re-
spond to NGF all originate inthe neural crest. The origi-
nal work identified sympathetic and sensory neurons as
the target tissues for NGF. Forthese cells, NGF is abso-
lutelyrequired, at certain stages intheirdevelopment, for
their survival. More recently, it has been shown that chro-
maffin cells of the adrenal medulla, while not requiring
NGF for survival, areprofoundly affected byit. Adrenal
medullary cells fromyounganimals, whetherin vitro (84)
orinvivo (85), respond to NGF treatmentwith an elabo-
ration ofneurites and a conversion into sympathetic neu-
rons. Clearly, apopulation ofneurons in the central ner-
vous systemisresponsive to NGF aswell. The cholinergic
neurons ofthe basal forebrain demonstrate increases in
choline acetyltransferase activity, neurite outgrowth, and
survival (86-88) when treated with the factor. Although
the response of the PC12 cells is the most dramatic, a
number ofother tumor cell lines respond to NGF in one
way orthe other. Certain humanneuroblastomas differen-
tiate in culture when NGF factor is added (89). A few
gliomas also have been shown to display increased neu-
rite outgrowth (90), and there are reports ofenzyme in-
duction in some other lines of pheochromocytoma (91).
The profound changes undergone by PC12 cells are the
clearest alterations seen so far in an experimental model.
Although NGF has no effect on survival, the reversible
differentiation causedby the factor involves virtually ev-
ery metabolic and morphological characteristic of the
cells.
Rapid, Membrane-Based Actions
Perhaps the most rapid changes seen in PC12 cells ex-
posedto NGF are alterations inthe structure ofthemem-
brane (92). Within a few seconds after the addition of
NGF, ruffles appear, the microvilli decrease in number,
and the density of the coated pits increases. These
changes are transient, even in the continuedpresence of
NGF, and the membrane returns to its ground state ap-
pearance within 7 min. Short-term changes in morphol-
ogy are also seen in the growth cone (93). Along with
these changes in structure come changes in membrane
properties. Among these are alterations in the ability of
cellsto adhere to aplastic substrate orto each other(94).
Changesin secondmessengerlevelshavebeen seenim-
mediately after the addition of NGF. cAMP levels have
been measured, and moderate, transient increases have
been reported (94), although these increases have not
been seen by others (95). Small changes in the flux of
Ca2 + have also been reported (96), but again, these
reports could not be substantiated by others (97). In-
creases in the hydrolysis of phosphoinositides are seen
within seconds (98), perhaps corroborating datain earlier
reports showing a somewhat slowerincrease in the incor-
poration ofinorganicphosphate intophosphatidylinositol
andphosphatidic acid(99). A synergisticrelationship be-
tweenNGF andbradykininforphosphatidylinositol turn-
over in PC12 cells has been reported (40).
Ithasbeen shown that NGF causes an activation ofthe
Na+, K+-pump ofPC12 cells (100). This increase can be
blockedby amiloride, an inhibitorofNa+ flux, and mim-
ickedbymonensin, a Na+ ionophore, suggestingthat the
pump is activated by aNGF-inducedincreasein Na+ in-
flux. Changes inthe transport ofanumberofothermate-
rials have also been reported. The model amino acids, a-
amino isobutyric acid and aminocyclopentane-1-carboxylic
acidwerebothtakenupmorereadilybycellstreatedwith
NGF (101). That these changes were specific to the up-
take ofamino acidswas shownby studies demonstrating
that there was no change in the uptake ofnucleosides or
of catecholamines.
Changes in Phosphorylation
Following tle first demonstrations that NGF treatment
ofPC12 cells changed thephosphorylation ofspecific cel-
lular proteins (102,103), there have been a number of
studies focusing on alterations in various kinases and
their substrates. The phosphorylation oftyrosine hydrox-
ylase is increased by treatment of the cells with NGF
(103), and the activity ofthe enzyme increases (104,105).
The increases inphosphorylation occur at several differ-
ent sites in the molecule (11,106) and seem to be caused
by increases in the activity of both cAMP-dependent
kinases andproteinkinase C. Glycogenphosphorylase ac-
tivity also in increased (107), probably by phosphoryla-
tion. The dependence of this effect on calcium ion sug-
gests the involvement of a calcium-dependent kinase.
A soluble protein of 100,000 molecular weight, called
NsplOO, shows a decreased phosphorylation upon nerve
growthfactoradditiontothe cells(108). The abilityto cap-
ture this effect of NGF in a cell-free preparation has al-
lowedthe design ofstudies onthemechanism. Ithasbeen
shown that the effect of NGF is to lower the activity of
the threonine-specific kinase phosphorylating NsplOO
(109), and that this effect of NGF is calcium-dependent
(110). There is evidence thatthislowered activitymaybe
due to the phosphorylation ofthe NsplOO kinase by pro-
tein kinase C (111). Recent studies indicate that NsplOO
is, in fact, elongation factor 2 (EF-2) (112).
The ribosomal protein S6 exhibits increasedphosphory-
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lation in cells treatedwith NGF (103,113). Again, the abil-
ityto capture this increase in acell-free systemprepared
from treated cells has allowed some detailedinformation
to be obtained. The kinase phosphorylating S6 has a
molecular weight of some 45,000 (114) and is itself acti-
vated by phosphorylation, probably by a cAMP-
dependent system. The changes in phosphorylation in
both EF-2 and S6 indicate the significant actions ofNGF
on protein synthesis in these cells, although the exact
functional consequences ofthese changes remain tobe ex-
plored.
Changes in phosphorylation also take place in the nu-
cleus (102) and may underlie the transcriptional altera-
tions caused by NGF. One proteinphosphorylated is part
of the nonhistone group and has a molecular weight of
about 30,000. A cell-free system reflectingthis alteration
has been obtained (115), but the function ofthe protein
and the nature ofthe kinasephosphorylatingitremain to
be elucidated.
As mightbe expected in view ofthe profound morpho-
logical changes occuringin the cells, several cytoskeletal
proteins show changes in phosphorylation. Vinculin is
amongthese (116), as are certainofthe neurofilamentpro-
teins(117) and a250,000 molecularweight, cytoskeletally
associated protein (118). The increased phosphorylation
ofthis latter protein can be seen in a properly prepared
cell-free system from NGF-treated cells. Thephosphory-
lation ofone ofthemicrotubule-associated proteinsis also
increased by treatment with NGF (119).
An increased phosphorylation of synapsin I has been
reported to occur after NGF treatment (120). The phos-
phorylationofthe NGF receptoralsohasbeen seen(121),
but does not seem to be influencedby NGF and its func-
tional significance is not known.
Alterations in the activities of a few specific kinases
have been reported. Among them are the kinase for the
250,000 dalton cytoskeletal protein (118), the S6 kinase
(103), a previously unidentified NGF-activated kinase
(122), the kinase phosphorylating Nspl00/EF-2 (110), and
protein kinase C (111). The identification ofspecific pro-
teins, the phosphorylation of which is altered, with at
least the presumption ofconcomitant alterations infunc-
tion, provides some indication ofhow atleast some ofthe
actions ofNGF on the cell are expressed at the molecu-
lar level.
Transcription-Dependent Alterations
Perhaps the fastest transcriptional alterations observed
thus far are the alterations in the expression of several
of the protooncogenes following NGF treatment (123).
Prominent amongthese is the c-fos, which isinduced 30-
to 50-fold within 30 min (124-126). The induction of on-
cogenesby NGF mayplay arole inthe differentiative ac-
tions ofthe factor on the cells because the introduction
ofspecificoncogenes, such as the v-src(127), the ras(128),
the N-ras (129), or the protein product of the ras (130),
causes a differentiation similar to that seen with nerve
growth factor. Further, the injection into the cells ofthe
antibody to the ras protein inhibits NGF-induced differ-
entiation (131).
The induction ofornithine decarboxylate also appears
to be an early and universal consequence ofthe actions
of NGF on its target cells (95,132,133). A 50- to 100-fold
increase in activity canbe seen within 5 hr(134). The in-
crease is clearly dependent on the synthesis of the or-
nithine decarboxylase mRNA(135). Unlike the induction
ofprotooncogenes, where afunctional link to the actions
ofNGF onthe cells is indicated, the inductionofomnithine
decarboxylase has been specifically disassociated from
the morphological alterations caused by the factor (132).
The increases in the transmitter-metabolizing enzymes
are alsolikelytobetranscriptional innature. The increase
in tyrosine hydroxylase activity in PC12h cells, about
2-fold over several days, appears to have characteristics
suggestive of transcriptional regulation (54), although
transcriptionalregulation hasnotbeen demonstratedfor-
mally here. Increases in the specific activity of choline
acetyltransferase have been documented repeatedly
(3,8,136), as have increases in the activities and forms of
acetylcholinesterase (18,137-139). It has been shown in
the latter case that the increases are blocked by treat-
ment with low concentrations of actinomycin D (138).
The levels ofa number ofother proteins in PC12 cells
are increasedby NGF treatment. Neuron-specific enolase
increases some several fold in the first few days oftreat-
ment(140). Increases are also seen inthe surface marker
Thy-1 (141,142). Induction ofsynapsin I hasbeenreported
(143), and changes in actin expression have been seen
(144), as have increases in the amount ofan unidentified
substrate for protein kinase C (145). Increases in neu-
rotensin(146,147), neuropeptide Y(148), andMAP-2(119)
have been reported. Increases in the levels of sodium
channels ontreated cells (52) are almost certainly depen-
dent on transcription as well.
Increases in the NILE protein have been extensively
investigated andhavebeen showntobe transcriptionally
based (149) This surface constituent, the NGF-inducible
large external (NILE) glycoprotein, has a molecular
weight of230,000 and is increased some 3-fold in NGF-
treated cells. It is found on both peripheral and central
neurons(150), aswell as on PC12 cells. Its chemical (151)
andbiochemical (152)properties have been detailed. Re-
cent work has shown that the NILE is, in fact, identical
tothe cell adhesionmolecule Li (153,154) andtheneuron-
glia cell adhesion molecule NgCAM (155).
Two interesting proteins decrease in PC12 cells after
NGF treatment. One is alactic acid dehydrogenase, found
because ofits nuclear localization and its ability to bind
to single-stranded DNA (156-158). The other is the
epidermalgrowthfactorreceptor(25,27,159). Decrease in
thislatterprotein, thereceptorforaknownmitogen, has
beenpostulated to be atleast inpart responsible for the
ability ofNGF to inhibit cell division(25,27), althoughin
neither case has the formal demonstration been made
thatthese decreases are dueto decreasesintranscription,
this seems likely in both cases.
Although direct and detailed studies on the synthesis
ofvariousmRNAs in PC12 cells treatedwith NGF seem
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imminent, only a few have appeared so far. An increase
in a specific gene sequence induced by NGF has been
reported (160), although noinformation onthe identity of
itsprotein product hasbeenforthcoming. More recently,
it has been found that NGF causes the accumulation of
an RNA that has sequence homology with a known reg-
ulator of transcription (161).
Neurite Outgrowth
While it seems likely that the complex changes in the
cell caused by nerve growth factor, such as synapse for-
mation, hypertrophy, and neurite outgrowth, would re-
quire transcriptional change, only in the case ofneurite
outgrowth has the subjectbeen explored experimentally.
Early studies with neuronal explants from fetal animals
indicated that the presence ofactinomycin D, in amounts
sufficient toblock RNAsynthesis, did notinterfere with
the ability ofNGF to elicit such neurites(162). Thus, the
conclusion, almost counter-intuitive, that transcription
was not required for neurite outgrowth, became estab-
lished. The PC12 model allowed areinspection ofthis con-
clusion. It was found that, in PC12 cells, RNA synthesis
inhibition did inhibit the generation of neurites (163).
However, when cells were treatedwith NGF and then the
neurites removed by separating the cells from the sub-
stratum, they regenerated neurites when replated, at a
very rapid rate and even in the presence ofinhibitors of
RNA synthesis. It was suggested thattheseprimed cells
had accumulated all the RNA synthesis-dependent mac-
romolecules necessary for neurite formation andneeded
only some nontranscriptional stimulus provided by NGF
to be able to form neurites. It was reasoned that in the
earlier studies, explantsfromfetalanimalsmade neurites
in an RNA-synthesis independent manner because they
had been removed from an NGF-sufficient environment
and were therefore primed. The present understanding
is that neurite generation requires the action ofNGF at
two loci, one at the site oftranscription and the other at
the level of the membrane.
Other Factors Acting on the Cells
Anumber ofother agents act onthe PC12 cells. Among
these are other neurite-promotingfactors, mitogens, and
agents acting to alter the phenotype ofthe cells. Among
the neurite-promoting agents is fibroblast growth factor.
Fibroblast growth factor induces clearneuriteoutgrowth
by PC12 cells (164), although the amount ofneurite out-
growth seen is less than that elicited by NGF. The per-
manence ofthese neurites is the subject ofsome moder-
ate controversy. The original reports showed that the
neurites elicited by fibroblast growth factor, like those
produced by treatment with dBcAMP, were transitory,
disappearing within several days even in the presence,
andwiththerepeatedaddition, offreshfibroblastgrowth
factor(164). Subsequentreports fromotherworkers have
presented data showing that fibroblast growth factor
producesneurites aspermanent asthose elicitedby NGF
(29). The reasons for this discrepancy are not known. A
neurite-inducing factor, isolated from salivaryglands, but
different from NGF, with a molecular weight of some
20,000, hasbeen reported (165). Neurites havebeen seen
aftertreatment ofthe cells withphospholipase (166), and
afterintroduction ofsrc(127) orras (128-130)oncogenes
into the cells. A form ofoutgrowth, similar to that seen
with NGF is produced when the cells are treated with
certain cAMP derivatives (167). Potentiation of NGF-
inducedneurite outgrow occurs upon treatment ofPC12
cells with adenosine (36,168) orwith specific gangliosides
(169,170). Neurite outgrowth, in the absence ofexogenous
NGF, can be seen when cells are plated on extracellular
matricesgeneratedbybovine corneal epithelial cells(171)
or astrocytes (172), and NGF-independent neurite
regeneration can be seen when PC12 cells are placed in
contact with Schwann cells (173).
Epidermalgrowthfactorhas amoderate mitogenic ac-
tion onthese cells(25). Thisactionis associatedwith some
ofthe same intracellular changes seen aftertreatment of
the cellswith NGF, and some ofthe same surface changes
take place as well (174).
Phenotypic changes in the cells occur upon treatment
with glucocorticoids. It is generally thought that these
steroids direct the PC12 cell toward a chromaffinlike
phenotype. There are increases in tyrosine hydroxylase
activity (136) caused by an increase in the transcription
ofthe tyrosine hydroxylase gene (12,13). Corticosteroid-
induced changes in catecholamine production have also
been reported (175-177), as have changes in the nature
ofthe transmitter-containingvesicles (175,178). The sharp
antagonismbetween NGF andthecorticosteroids seenin
adrenal cell cultures (84) has not been seen with PC12
cells, although some inhibition of NGF-induced neurite
outgrowthby dexamethasone hasbeenreported(178). Re-
cent studies have shown thattreatmentwith dexametha-
sone decreases the number of NGF receptors on the
PC12 cell surface (179). There are reports that sodium
butyrate alters the phenotypic characteristics of PC12
cells and guides them into a chromaffinlike pattern
(180,181). It seems fair to say that although factors with
differentiating or neurotrophic activity for PC12 cells
have been identified, none hasbeen shown to have exactly
the same combination ofactivitiesexhibitedby NGF. The
effects ofa number ofother agents acting on PC12 cells
are summarized in Thble 2.
Comparison with Normal Cell
Counterparts
As mentioned previously, the PC12 is a clone derived
from arat adrenal medullary tumor(1). The classification
of these tumors is based on their morphological and
histochemical properties compared to theirnormal coun-
terparts from differentphases ofembryonal development
(187). The adrenal medullary cells are derived embryolog-
ically from the neural crest. Cells that develop in the
adrenal medullafrom neural crest stem cells are ofthree
major types: sympathetic principal neurons, adrenal chro-
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Table 2. Comparison of PC12 cells with nornal cell counterparts
Property
Growth
Morphology
Cytoskeletal composition
Major catecholamine content
Neurotransmitters and/or
neuropeptide content
Responsiveness to EGF and
the loss ofproliferative
potential
Neurotransmitters receptors
Voltage-dependent ion
channels
Polysialoglycolipids
PC12 cells
Cell line
Round, 20-40 Am cell body
diameter; heterogeneous in
size, density, and low number
ofgranules 30-350 nm (5)
( and y actin (144), tubulin and
microtuble-associated proteins
(chartins) (224); epithelial-like
cytokeratins, and neuronal
intermediate-size filaments
(225);
Dopamine, norephinephrine (228)
Acetylcholine (6), y-aminobu-
tyric acid (231)
Yes (25); heterodown regulation
of EGF receptors during
NGF-induced differentiation
(25,27)
Acetylcholine muscarinic (33)
and nicotinic (2); adenosine
(36,235); benzodiazepines (236)
Sodium channels (188,189);
voltage dependent (41) and
calcium dependent (41,53)
potassium channels, calcium
channels (244,245)
Expressed upon NGF induced
differentiation (193)
Chromaffin cells
Primary culture
Round, 20 pm cell body
diameter; abundant vesicles
of 150-350 nm (222)
Tubulin, actin, a-fodrin,
myosin (226)
Norepinephrine, epinephrine (229)
Enkephalins, substance P,
vasoactive intestinal peptide,
somatostatin, neurotensin
(232)
No; absence of EGF receptors
on the cell surface
(unpublished)
Acetylcholine muscarinic (237)
and nicotinic (237); P-adrenergic
receptors (238);
dopaminoceptors (239);
neuropeptide receptors (240)
Sodium (240), potassium (246),
and calcium channels (247)
Unknown
Sympathetic neurons
Primary culture
Long neurites, 40- 50 ,um
diameter, vesicle size 50 nm
(223)
Typical neuronal cytoskeleton
(227)
Norepinephrine (230)
Acetylcholine (230),
somatostatin, substance P
(233), enkephalins (234)
Unknown
Nicotinic (241); adrenergic
(242); enkephalins, substance
P (243)
Sodium, potassium (248), and
calcium channels (191)
Present (192,249)
maffin cells, and small intensely fluorescent (SIF) cells.
These cells all synthesize and store catecholamines, but
differ in cell morphology, neurotransmitter-synthetic ma-
chinery, and type and content ofneurotransmitter vesi-
cles. In some respects SIF cells appear intermediate in
phenotype between sympathetic neurons and adrenal
chromaffin cells. PC12 cells, like embryonal neural crest
cells, have the characteristics ofimmature monoaminer-
gic neurons in that they have the ability to synthesize
both adrenergic and cholinergic neurotransmitters (178).
NGF treatment produces, reversibly, the sympathetic
neuronal phenotype andglucocorticoid produces, revers-
ibly, the chromaffmlike phenotype. Thus, itisappropriate
to compare the properties of PC12 cells treated with
these agents with those of their normal counterparts.
Adrenal medullary cells in primary culture, unlike
PC12, have afinite lifetime. They do notrequire NGF for
survival. The catecholamines are primarily norepin-
ephrine andepinephrine (182), in contrast tothe prepon-
derance ofdopamine in the PC12 cells. The adrenal cells
have bothnicotinic andmuscarinic acetylcholine receptors
(183,184) as do the PC12 cells. Adrenal cells contain, syn-
thesize, and secrete enkephalins (185); there are no
reports ofcomparable activities inPC12 cells. Treatment
with NGF increases thetyrosine hydroxylase levelsofthe
cells fromfetal animals in culture(186). Underappropri-
ate conditions, neurite outgrowth can also be produced
from such cells(84); such outgrowth cannotbe seenin cul-
tures from mature animals. This neurite outgrowth is
prevented by the simultaneous presence of corticoster-
oids; no comparable amount ofinhibition ofNGF-induced
neurite outgrowth hasbeen seen with PC12 cells. There
are receptors for NGF on cultured adrenal medullary
cells, receptors that seem to decline or disappear as the
animal ages (186), but these receptors have not been
described in detail.
Sympathetic neurons, ofcourse, also have a finite life-
time in culture. They generally require NGF in the
medium for survival, but, unlike with PC12 cells where
removal of NGF leads simply to loss of differentiated
properties, removal ofNGF hereleadsto cell death. Sym-
pathetic neurons, like NGF-treated PC12 cells, do not di-
vide. The major catecholamine neurotransmnitter ofdiffer-
entiated PC12 cells is dopamine; norepinephrine is the
predominant catecholamine in sympathetic neurons;
acetylcholine is present in both. The nicotinic acetylcho-
linereceptorsfound on sympathetic neurons appeartobe
identical tothose seenonPC12 cells(30). Although there
are discrepancies in the reportsfromvariouslaboratories,
the broad outlines ofthe chemistry ofthe NGF receptors
on PC12 cells and on sympathetic neurons, eg., specific-
ity, saturability, both low- and high-affinity sites, are also
about the same. Differentiated PC12 cells display large
numbers of voltage-dependent sodium channels
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(52,188,189), as do sympathetic neurons, and the differen-
tiation also produces a complement ofcalcium channels,
mainly N and/or T type that are dihydropyrimidine-
insensitive (190), similar to those seen on mature sym-
pathetic neurons (191). Tetanus toxin binding sites, the
hallmark of mature neurons in culture, found on termi-
nally differentiated sympathetic neurons (192), appear on
the neurites and the growth cones of PC12 cells after
several days of treatment with NGF (193). The rapid
changes in surface morphology seen when PC12 cells are
exposed to NGF (92) are seen with sympathetic neurons
in culture as well (194). Finally, it has been shown that
antisera raised against mature sympathetic neurons
grown in culture recognized antigens in differentiated
PC12 cells (195). A number ofthe major characteristics
ofthe PC12 cells andtheirnormal counterparts are sum-
marized in Table 3.
Mechanisms of Differentiation
Based on what is currently known, an outline of the
pathway(s) by which NGF causes the differentiation of
PC12 cells canbe constructed. Clearly, thefirst stepisthe
bindingofNGF to its receptor. Onthe PC12cells, asmen-
tionedbefore, there are two classes ofreceptors, and the
Table 3. Other agents acting on PC12 cells.
Agent Origin Biochemical properties Cellular response Reference
Sodium butyrate Synthetic
Corticosteroids
Neurite-inducing factor
Fibroblast growth
factors
Epidermal growth
factor
Gangliosides
Soluble glycosamino
glycans; Mg2"
cAMP, forskolin
Phorbol esters
ras and v-src
oncogenes; antibodies
to ras p21
Adenosine derivatives
Synthetic
Mouse salivary glands
Brain or pituitary
Mouse salivary gland
Bovine brain
Animal and plant
tissue
Synthetic
Synthetic
Rous sarcoma virus,
Harvey murine
sarcoma virus
Synthetic
Culture broth alkaloid of
Nocardiopsis sp.
Protein; Mr: 20;
processed from NGF
activator
Proteins; Mrs: 16-17
pI: 5-7; 9.6
Protein; Mr: 6.04
stimulates cell
proliferation
Sialoglycolipids;
modulate EGF
receptor affinity;
regulate tubulin gene
expression; release of
neurotropic glycoproteins
Dextran sulfate
heparin, putative
fibronectin cell binding
tetrapeptide Arg-Gly-
Asp-Ser
TPA, PMA, modulate
EGF response,
enhancers offorskolin-
induced cAMP
formation
Inhibitors of adenosyl-
methio nine-methyl-
transferases
Induction of
chromaffinlike
phenotypic markers;
increased cell adhesion;
growth arrest
Induction of
chromaffinlike
phenotype; increased
tyrosine hydroxylase,
and decreased choline
acetyltransferase
activity
Neurite outgrowth
Neurite outgrowth
Stimulates thymidine
incorporation,
activation of ornithine
decarboxylase
Growth arrest;
neurotrophic;
enhancers of NGF-
induced neurite
outgrowth
Inhibitors of NGF-
induced neurite
outgrowth
Enhancers of NGF-in-
duced neurite outgrowth
No effects on NGF
activity on PC12;
induction of ornithine
decarboxylase activity
Neurite outgrowth
Specific blockers of NGF
action
Specific inhibitor of NGF
action
(180,181)
(136,175)
(165)
(29,164,171)
(25)
(170,213-215)
(29,216,217)
(36,167,168)
(218,219)
(127,128,131)
(220)
13S4
K-252a (221)DIFFERENTIATION OF PC12 CELLS
weight ofevidence is that the high-affinity, slow receptor
is the physiologically relevant one. The evidence for this
includes data showingthat the concentration dependence
for binding to the high-affinity site matches the concen-
tration dependence ofmost ofthe actions ofNGF, that it
is the high-affinity receptor that is internalized, and that
mutants lackingthe high-affmity receptor do notrespond
to NGF. It should be remembered, however, that there
are several normal cells that have onlylow-affinity recep-
tors, and that some functions ofNGF seem to be tied to
that receptor, rather than to the high-affinity site (196).
The relationship ofthe high-affinity receptor to the low-
affinty receptor is a subject of intense current interest,
and maybe central to the question ofsignal transduction
by the receptor. Clearly, the high-affinity receptor has a
highermolecular weight than the low-affinity receptor, al-
though reports from differentlaboratories differ as to the
amountbywhich itis higher. Clearly, also thebinding site
proteins ofthe two receptors are identical (22). There are
suggestions that the high-affinity receptor has an addi-
tional protein subunit that maybe aG-ras-like protein (22)
for coupling the receptor to thegeneration ofanintracel-
lular message, or a C-src-like protooncogene (197) for in-
troducing atyrosine kinase into the pathway. In this lat-
ter regard, it is clear that the NGF receptoritselfis not
atyrosine kinase, nor even possesses an ATPbinding site
on its cytoplasmic domain(198,199). Itis alsopossible that
the associatedproteins couldrepresent somemembranal
cytoskeletal structure involved in anchorage, sequestra-
tion, and/or internalization of the high-affinity receptor,
thereby conferring their known resistance to detergent
extraction and proteolytic attack.
It is clear that although the NGF and its receptor are
internalized (197,200), and that there are NGF binding
sites on the nucleus (201), the entrance of NGF into the
cell is not necessaryfor, andprobably does notplay arole
in, themechanismbywhich NGF directs intracellular dif-
ferentiative events. The evidence consists of studies in
which NGF was introduced directly into the cytoplasm of
PC12 cells (202), circumventing the surface receptor.
When this was done the cells did not respond. Cognate
experiments showed thatwhenantibody to NGF was in-
troduced into the cyoplasm, ostensibly preventing NGF
from transiting to the nucleus, the cells responded nor-
mally to exogenous administration ofthe factor. The in-
terpretation that hasbeengiven these studies is thatthe
combination ofNGF withits receptoristhe signalinitiat-
ingits action; internalization isthought to beforthe pur-
pose of signal termination, not signal generation.
Although itis assumed that some secondmessenger, or
combination ofsecond messengers, is involved in the ac-
tions ofNGF, theidentification ofthat secondmessenger
has not been reported. It has been suggested that NGF
differentiation requires cAMP as a second messenger.
This suggestion was based mainly on the findings that
NGF treatment caused a transient, modest increase in
cAMPlevels in PC12 cells(94), cAMP derivatives elicit a
form ofneurite outgrowth from the cells (94), and treat-
ment of the cells with cAMP derivatives modulate the
synthesis ofthe same group ofproteins(203) andproduce
similar changes in phosphorylation of several proteins
(102,103), as does NGF.
Systematic investigations, however, using established
criteria by which second messenger function is validated
showed that these criteria were not fulfilled for cAMP
(167,168). It is now thought that agents that increase in-
tracellularlevels ofcAMPforprolongedperiods stimulate
an early, transient outgrowth and may exert a main-
tenance effect on the neurite network established by
NGF (168). The overall role of cAMP in the differentiat-
ingeffects ofNGF is poorly understood. The recent work
with clonal variants ofPC12 cells with defects in cAMP-
dependent protein kinases (61) has shown that NGF in-
duces ornithine decarboxylase normally in these cells, but
the phosphorylation ofcertain sites on tyrosine hydrox-
ylase and ofthe ribosomal protein S6was decreased(106),
implying arole for cAMP in the NGF-induced activation
ofspecific anabolic enzymes. Thus, the body ofevidence
argues against a major, critical role of cAMP alone in
NGF-induced differentiation, but a secondaryrole in cer-
tain of the actions of NGF seems likely.
The role ofcalcium ion in the actions of NGF may also
be secondary. Original experiments showingthat NGF in-
duced achange in calciumfluxes(96)couldnotbe substan-
tiated (97). However, a recent study using Quin-2 with
PC12 cells in suspension or Fura-2 in single PC12 cells
have clearly shown that a rapid rise ofcytosolic Ca2+ is
induced by low concentrations of NGF (204). There are
also recent reports that the actions of NGF on phos-
phoinositide turnover (98) and on the phosphorylations of
glycogen phosphorylase (107) and NsplOO/EF-2 (109) are
dependent on the presence ofCa2 . Since other actions
of NGF are clearly not calcium dependent, the role of
Ca2+ may be, like the role of cAMP, secondary.
That NGF treatment stimulates the formation of ino-
sitolphosphates inthe cells within 15 secis clear(98). The
involvement ofthe products ofincreasedphosphoinositide
turnover in the elevation ofcellular calcium (204) and the
activation ofprotein kinase C (111), both reported to oc-
curafter NGF addition, is also biochemically consistent.
But the relationship ofphosphoinositide turnover to the
overall differentiating effects ofNGF isintriguingbutun-
proven.
The possibility that NGF acts by altering transmem-
brane fluxes ofmonovalent ions has been explored. Early
studies uncovered arapid effect ofNGF on the Na+ ,K+
pump ofPC12 cells (100,205,206). The stimulation ofthe
Na+ ,K+-ATPase as measured by the ouabain-sensitive
22Na+ efflux(205) or86Rb+ influx(100,206) occurswithin
minutes and is maximal within 30 min after NGF addi-
tion. Since the stimulation of the pump was completely
blocked by amiloride, mimicked by the Na+ ionophore
monensin, and seemed due to an increase in Na+ influx,
it was suggested that the acceleration of the Na+ ,K+
pump was an event secondary to an increase in Na+in-
flux mediated by a Na+ ,H+ exchanger. In support of a
role for Na+ in NGF-induced differentiation is the find-
ingthat substitution ofcholineforNa+ inhibitedthe neu-
rite outgrowth ofPC12 cells (207). However, in a recent
examination ofthe effect ofNGF onthe Na+-H+ antiport
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in PC12 cells using a fluorescent probe sensitive to
changes in the cytoplasmic pH, no activation was ob-
served (208). It will be interesting to determine ifother
ion transport systems in the plasma membranes of the
PC12 cells are influenced by addition of NGF.
Thus there is evidence that several secondmessengers
play some role in the actions ofNGF. The dataonprotein
phosphorylation is consistent with such apicture. Thatis,
there is evidence that Ca2+ is required for some of the
phosphorylations (107,109), but not for others. There is
evidence that cAMP is involved in some (114), but not in
others. Indeed, there are data showing that both second
messengers are needed forthe complete actions ofNGF
on the phosphorylation ofa single protein (106). The pic-
ture that could be drawn is that the actions of NGF are
mediated by several parallel pathways, perhaps somewhat
redundantinfunction, subsets controlledby different sec-
ond messengers.
These pathways are likely to be chains ofkinases. Such
apicture emerges fromthe observation thatprotein kin-
ase C is activated by NGF and phosphorylates a kinase
that phosphorylates the cytoplasmic protein called
NsplOO (111), recently identified as elongation factor 2
(EF-2) (112). Another independent kinase chain appears
tobe involved inthephosphorylation oftheribosomalpro-
tein S6, in which the S6kinaseis itselfactivated byphos-
phorylation, probablyby a cAMP-dependent kinase (114).
These pathways lead to the phosphorylation ofa number
ofimportant proteins invarious compartments in the cell,
enumerated in an earlier section, the phosphorylation
presumably altering their functional characteristics.
In the absence of any other data, it can be suggested
that thesephosphorylations andalteredfunctions, taken
together, provide thefabric ofthe cellularalterations com-
prising differentiation. Sincewe knowthat atleast one of
these phosphorylations involves a nonhistone protein in
the nucleus (102,115), it requires no great leap ofimagi-
nation to suggest that the NGF-inducedphosphorylation
ofnuclearproteins isresponsible forthe NGF-dependent
alterations in the transcription of specific genes.
The authorsappreciate the helpful comments ofDrs. Margarita Con-
treras, Shinichi Koizumi, Brian Rudkin, and Peter Lelkes during the
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